GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Filed today
—
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Natural Capsules Ltd

Natural Capsules Ltd: Subsidiary stake dilution due to non-rights issue participation

FUNDRAISE ◆ Monitor Closely MEDIUM RISK
📅 Filed on BSE: 29 Jul 2026, 07:02 PM IST  ·  BSE ID: c6294fb3-3563-46e6-8a5e-db19caad8965
View Original BSE Filing (PDF)
💡
In Simple Terms
The company chose not to buy more shares in its subsidiary, leading to a slight reduction in ownership.
🤖 AI Summary
  • Natural Capsules Ltd's board approved non-participation in subsidiary rights issue.
  • Subsidiary Natural Biogenex Private Limited's equity stake diluted by 2.18%.
  • Parent company holding reduced from 68.96% to 66.78% of paid-up capital.
  • Non-participation due to strategic fund allocation on other business matters.
🔢 Key Numbers — exact figures from BSE filing, not rounded
Equity stake dilution in subsidiary
2.18 %
Parent company shareholding prior to dilution
1,99,99,996 Equity Shares, 68.96% of the paid-up capital
Parent company shareholding post dilution
1,99,99,996 Equity Shares, 66.78 % of the revised paid-up capital
Subsidiary Turnover (last FY)
Rs. 13.43 Crore
Subsidiary Net Worth (last FY)
Rs. 81.24 Crore
Subsidiary Profit/Loss (last FY)
Rs - 43.30 crore
🏢 How This Affects the Company
📈
Business Impact
The company's effective control over the subsidiary remains, as it continues to be classified as such. The business operations of the subsidiary are not directly impacted by this ownership change, though its capital structure is altered.
💰
Financial Impact
Natural Capsules Limited avoids deploying capital in the subsidiary's rights issue, freeing funds for other strategic uses. The company's investment value in the subsidiary is diluted in terms of percentage ownership.
⚙️
Operational Impact
No direct operational changes are indicated for Natural Capsules Limited or its subsidiary from this decision. The subsidiary will continue its operations with a revised equity structure.
⚠️
Risk Impact
The risk profile remains unchanged as the subsidiary status is maintained. Potential risks associated with capital deployment in the subsidiary are avoided.
👥 What This Means For Shareholders
✅
Action Required
No specific action is required from shareholders regarding this event.
👤
Who Is Affected
All shareholders of Natural Capsules Limited are affected by the change in ownership percentage of their indirect investment in the subsidiary.
🔍
Management Signal
Management is prioritizing strategic allocation of funds towards other business matters over further investment in the subsidiary's rights issue.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
Future rights issues or capital raising by subsidiary Natural Biogenex.
Performance updates for Natural Biogenex Private Limited.
Natural Capsules Ltd's reported financial results and fund allocation.
MEDIUM RISK Subsidiary's reported loss and equity dilution signal financial considerations.
💡 Investor Takeaway
Natural Capsules Limited's stake in subsidiary Natural Biogenex Private Limited diluted by 2.18% to 66.78% after management decided not to subscribe to the rights issue, citing strategic fund allocation.
⚖️ Strengths & Concerns

✅ Positives

  • Strategic fund allocation confirmed by management for alternative business growth opportunities.
  • Subsidiary Natural Biogenex Private Limited remains a subsidiary post-dilution event.

⚠️ Concerns

  • Equity stake in subsidiary Natural Biogenex Private Limited reduced by 2.18% to 66.78%.
  • Subsidiary reported a loss of Rs. -43.30 crore for the last financial year.
❓ Frequently Asked Questions
What is the percentage stake dilution for Natural Capsules Ltd in its subsidiary?
Natural Capsules Ltd's equity stake in Natural Biogenex Private Limited is diluted by 2.18%.
What was Natural Capsules Ltd's shareholding in its subsidiary before the rights issue?
Prior to the dilution, Natural Capsules Ltd held 1,99,99,996 Equity Shares, representing 68.96% of the paid-up capital.
What is the shareholding of Natural Capsules Ltd in its subsidiary after the rights issue?
Post completion of the rights issue, Natural Capsules Ltd holds 1,99,99,996 Equity Shares, representing 66.78% of the revised paid-up capital.
What were the financial figures for the subsidiary Natural Biogenex Private Limited last financial year?
For the last financial year, Natural Biogenex Private Limited had a Turnover of Rs. 13.43 Crore, Net Worth of Rs. 81.24 Crore, and a Profit/Loss of Rs - 43.30 crore.
Why did Natural Capsules Ltd not participate in the subsidiary's rights issue?
Natural Capsules Ltd did not participate based on strategic allocation of funds on other business matters.

Questions based on this BSE filing only. For information purposes.

You've read one filing

There are 32,000 more, and one of them is about a company you own

Follow a company and we'll email you the moment it files again — explained, not just forwarded. Free.

  • Follow companies and get filings by email
  • Save any filing to read later
  • Two full AI analyses every month, free

No card needed. Sign in with Google in two taps.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.